Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,868 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.
Schmid P, Turner NC, Barrios CH, Isakoff SJ, Kim SB, Sablin MP, Saji S, Savas P, Vidal GA, Oliveira M, O'Shaughnessy J, Italiano A, Espinosa E, Boni V, White S, Rojas B, Freitas-Junior R, Chae Y, Bondarenko I, Lee J, Torres Mattos C, Martinez Rodriguez JL, Lam LH, Jones S, Reilly SJ, Huang X, Shah K, Dent R. Schmid P, et al. Among authors: jones s. Clin Cancer Res. 2024 Feb 16;30(4):767-778. doi: 10.1158/1078-0432.CCR-23-2084. Clin Cancer Res. 2024. PMID: 38060199 Free PMC article. Clinical Trial.
5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study.
Ascierto PA, Dréno B, Larkin J, Ribas A, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Atkinson V, Dutriaux C, Garbe C, Hsu J, Jones S, Li H, McKenna E, Voulgari A, McArthur GA. Ascierto PA, et al. Among authors: jones s. Clin Cancer Res. 2021 Oct 1;27(19):5225-5235. doi: 10.1158/1078-0432.CCR-21-0809. Clin Cancer Res. 2021. PMID: 34158360 Free PMC article. Clinical Trial.
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers.
Jhaveri K, Chang MT, Juric D, Saura C, Gambardella V, Melnyk A, Patel MR, Ribrag V, Ma CX, Aljumaily R, Bedard PL, Sachdev JC, Dunn L, Won H, Bond J, Jones S, Savage HM, Scaltriti M, Wilson TR, Wei MC, Hyman DM. Jhaveri K, et al. Among authors: jones s. Clin Cancer Res. 2021 Jan 15;27(2):447-459. doi: 10.1158/1078-0432.CCR-20-2657. Epub 2020 Nov 4. Clin Cancer Res. 2021. PMID: 33148674 Clinical Trial.
Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.
Advani RH, Lebovic D, Chen A, Brunvand M, Goy A, Chang JE, Hochberg E, Yalamanchili S, Kahn R, Lu D, Agarwal P, Dere RC, Hsieh HJ, Jones S, Chu YW, Cheson BD. Advani RH, et al. Among authors: jones s. Clin Cancer Res. 2017 Mar 1;23(5):1167-1176. doi: 10.1158/1078-0432.CCR-16-0772. Epub 2016 Sep 6. Clin Cancer Res. 2017. PMID: 27601593 Free PMC article. Clinical Trial.
Strontium isoscape of sub-Saharan Africa allows tracing origins of victims of the transatlantic slave trade.
Wang X, Bocksberger G, Arandjelovic M, Agbor A, Angedakin S, Aubert F, Ayimisin EA, Bailey E, Barubiyo D, Bessone M, Bobe R, Bonnet M, Boucher R, Brazzola G, Brewer S, Lee KC, Carvalho S, Chancellor R, Cipoletta C, Cohen H, Copeland SR, Corogenes K, Costa AM, Coupland C, Curran B, de Ruiter DJ, Deschner T, Dieguez P, Dierks K, Dilambaka E, Dowd D, Dunn A, Egbe VE, Finckh M, Fruth B, Gijanto L, Yuh YG, Goedmakers A, Gokee C, Gomes Coelho R, Goodman AH, Granjon AC, Grimes V, Grueter CC, Haour A, Hedwig D, Hermans V, Hernandez-Aguilar RA, Hohmann G, Imong I, Jeffery KJ, Jones S, Junker J, Kadam P, Kambere M, Kambi M, Kienast I, Knudson KJ, Langergraber KE, Lapeyre V, Lapuente J, Larson B, Lautenschläger T, le Roux P, Leinert V, Llana M, Logan A, Lowry B, Lüdecke T, Maretti G, Marrocoli S, Fernandez R, McNeill PJ, Meier AC, Meller P, Monroe JC, Morgan D, Mulindahabi F, Murai M, Neil E, Nicholl S, Niyigaba P, Normand E, Ormsby LJ, Diotoh O, Pacheco L, Piel A, Preece J, Regnaut S, Richard FG, Richards MP, Rundus A, Sanz C, Sommer V, Sponheimer M, Steele TE, Stewart FA, Tagg N, Tédonzong LR, Tickle A, Toubga L, van Schijndel J, Vergnes V, Njomen NW, Wessling EG, Willie J, Wittig R… See abstract for full author list ➔ Wang X, et al. Among authors: jones s. Nat Commun. 2024 Dec 30;15(1):10891. doi: 10.1038/s41467-024-55256-0. Nat Commun. 2024. PMID: 39738027 Free PMC article.
A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries.
Grossman A, Prata N, Jones S, Läser L, Ganatra B, Lavelanet A, Williams N, Asmani C, Elamin H, Ouedraogo L, Maribe LS, Gbenou DV, Hien YC, Dadjoari M, Dao F, Adame Gbanzi MC, Mulunda Kanke R, Biayi Kanumpepa F, Dlamini D, Mefane GM, Bantiewalu SH, Brantuo MNA, Sentumbwe-Mugisa O, Mugahi R, Ojo OA, Aderoba AK, Rehnström Loi U. Grossman A, et al. Among authors: jones s. Reprod Health. 2024 Dec 27;20(Suppl 1):195. doi: 10.1186/s12978-024-01898-8. Reprod Health. 2024. PMID: 39731093 Free PMC article.
Improving outcomes for very preterm babies in England: does place of birth matter? Findings from OPTI-PREM, a national cohort study.
Pillay T, Seaton SE, Yang M, Bountziouka V, Banda V, Campbell H, Dawson K, Manktelow BN, Draper ES, Modi N, Boyle EM, Rivero-Arias O; Contributing neonatal units and leads. Pillay T, et al. Arch Dis Child Fetal Neonatal Ed. 2024 Dec 27:fetalneonatal-2024-327474. doi: 10.1136/archdischild-2024-327474. Online ahead of print. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 39730195
11,868 results
You have reached the last available page of results. Please see the User Guide for more information.